Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



KIDRON NADAV Create: Alert

All | News | Filings
Date FiledTypeDescription
01/11/2022 4/A KIDRON NADAV (President and CEO) has filed a Form 4 on ORAMED PHARMACEUTICALS INC.
Txns: Granted 150,000 shares @ $0
Paid exercise price by delivering 48,752 shares @ $13.89, valued at $677.2k
Granted 63,000 shares @ $0
Granted 107,000 options to buy @ $13.89, valued at $1.5M
12/07/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/07/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy